Physician
Texas Physicians Primary Care, PLLC
Texas Physicians Primary Care, PLLC was paid $4.83M by Medicaid between Dec 2018 and Dec 2024, across 82 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoTEXAS PHYSICIANS PRIMARY CARE, PLLC
MESQUITE, TX 75149
MESQUITE, TX 75149
33aNPI1962800284assigned 12/18/2014
33bProvider typePediatrics Physician
28Total paid$4.83M
24GClaims179,049
24DCodes billed82
24AFirst – last monthDec 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#89 of 1,136
Median peer was paid$329K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25 | $238.72 | |
| 2020 | 6,985 | $173K | |
| 2021 | 42,484 | $1.00M | |
| 2022 | 50,193 | $1.38M | |
| 2023 | 45,051 | $1.30M | |
| 2024incomplete | 34,311 | $979K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 21,942 | 18,536 | $964K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 28,992 | 22,508 | $914K |
| 99091 | 9.5% | 3,047 | 2,939 | $459K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.9% | 9,440 | 8,588 | $431K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.4% | 3,719 | 3,554 | $311K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.2% | 3,910 | 3,713 | $300K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.6% | 2,446 | 2,264 | $173K |
| 92567 | 3.0% | 12,402 | 11,786 | $143K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.0% | 14,006 | 7,850 | $143K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.9% | 11,121 | 5,285 | $142K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.4% | 1,898 | 1,681 | $118K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 8,804 | 8,281 | $113K |
70 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.2% | 1,753 | $108K |
| 99203 | Doctor's office visit, new patient (routine) | 1.6% | 1,579 | $78K |
| 99385 | 1.4% | 938 | $66K | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.3% | 876 | $62K |
| 99384 | <1% | 422 | $39K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,818 | $36K |
| 87631 | <1% | 532 | $33K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 386 | $30K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,486 | $28K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,331 | $24K |
| 99383 | <1% | 266 | $22K | |
| 99381 | <1% | 245 | $15K | |
| 90461 | <1% | 3,935 | $13K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 251 | $11K |
| 81025 | <1% | 1,280 | $8K | |
| 83655 | <1% | 714 | $6K | |
| 81002 | <1% | 2,283 | $6K | |
| 0001A | <1% | 139 | $5K | |
| 0002A | <1% | 130 | $5K | |
| 0071A | <1% | 121 | $5K | |
| 0072A | <1% | 97 | $4K | |
| 99382 | <1% | 42 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 411 | $3K |
| 87807 | <1% | 269 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 309 | $2K |
| 85018 | <1% | 882 | $2K | |
| 90619 | <1% | 1,026 | $1K | |
| 99406 | <1% | 114 | $850.94 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 17 | $660.65 |
| 3044F | <1% | 229 | $560.00 | |
| 0003A | <1% | 12 | $480.00 | |
| 0012A | <1% | 12 | $401.00 | |
| 90686 | <1% | 2,084 | $289.39 | |
| 90656 | <1% | 158 | $157.24 | |
| 93000 | <1% | 12 | $142.41 | |
| 90715 | <1% | 776 | $80.68 | |
| 96127 | <1% | 132 | $69.30 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 340 | $49.90 |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,361 | $41.30 |
| 90677 | <1% | 336 | $31.35 | |
| 99173 | <1% | 12,475 | $28.23 | |
| 90633 | <1% | 1,066 | $28.11 | |
| 82948 | <1% | 12 | $25.38 | |
| 90651 | <1% | 1,235 | $18.30 | |
| 91300 | <1% | 374 | $14.53 | |
| 91301 | <1% | 37 | $14.14 | |
| 90647 | <1% | 335 | $12.25 | |
| 36416 | <1% | 1,306 | $5.55 | |
| 90734 | <1% | 413 | $4.35 | |
| 90697 | <1% | 321 | $1.77 | |
| 91307 | <1% | 246 | $1.53 | |
| 90670 | <1% | 1,269 | $0.26 | |
| 90621 | <1% | 120 | $0.25 | |
| 90710 | <1% | 1,122 | $0.11 | |
| 90681 | <1% | 439 | $0.08 | |
| 90723 | <1% | 292 | $0.05 | |
| 90620 | <1% | 26 | $0.04 | |
| 90648 | <1% | 210 | $0.04 | |
| 90688 | <1% | 67 | $0.02 | |
| 3074F | 0% | 306 | $0.00 | |
| 3079F | 0% | 115 | $0.00 | |
| 90696 | 0% | 446 | $0.00 | |
| 3080F | 0% | 207 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 19 | $0.00 |
| 90698 | 0% | 68 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 13 | $0.00 |
| 3075F | 0% | 20 | $0.00 | |
| 90700 | 0% | 196 | $0.00 | |
| 3078F | 0% | 205 | $0.00 | |
| 3077F | 0% | 258 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNAVEED, SYED (MANAGING MEMBER)
| Provider | Location | Paid |
|---|---|---|
| National Clinical Labs | Lisle, IL | $6.17M |
| Genesis Diagnostic Services INC | Farmers Branch, TX | $23K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.